Cargando…

Trajectories of systemic agent use and associated depression- and anxiety-related health care costs among patients with psoriasis

BACKGROUND: Systemic treatment patterns and related mental health disorders and economic burden among patients with psoriasis are largely unknown. OBJECTIVE: To assess systemic treatment patterns and associated depression and anxiety-related health care costs among patients with psoriasis initiating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milan, Raymond, LeLorier, Jacques, Latimer, Eric A., Brouillette, Marie-Josée, Holbrook, Anne, Litvinov, Ivan V., Rahme, Elham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391576/ https://www.ncbi.nlm.nih.gov/pubmed/35996750 http://dx.doi.org/10.1016/j.jdin.2022.06.018

Ejemplares similares

Sex Differences in the Patterns of Systemic Agent use Among Patients With Psoriasis: A Retrospective Cohort Study in Quebec, Canada
por: Milan, Raymond, et al.
Publicado: (2022)

Sex differences in factors associated with switch between systemic agents among individuals with psoriasis: A retrospective cohort study in Quebec, Canada
por: Milan, Raymond, et al.
Publicado: (2021)

Performance of the high-dimensional propensity score in adjusting for unmeasured confounders
por: Guertin, Jason R, et al.
Publicado: (2016)

Head to head comparison of the propensity score and the high-dimensional propensity score matching methods
por: Guertin, Jason R., et al.
Publicado: (2016)

Bias within economic evaluations – the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug
por: Guertin, Jason R, et al.
Publicado: (2015)

Pharmacologically pertinent period of effect (PPPE)
por: Suissa, Melanie, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Fosfomycin for Treatment of Uncomplicated Urinary Tract Infections in Ontario
por: Perrault, Louise, et al.
Publicado: (2017)

Cost effectiveness of ‘on demand’ HIV pre-exposure prophylaxis for non-injection drug-using men who have sex with men in Canada
por: Ouellet, Estelle, et al.
Publicado: (2015)

A Cost-Effectiveness Analysis of Biomarkers for Risk Prediction in Atrial Fibrillation
por: Nakhlé, Gisèle, et al.
Publicado: (2023)

A Case of Intermittent Left Bundle Branch Block
por: Saad, Syed M, et al.
Publicado: (2021)

Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin
por: Mitchell, Dominic, et al.
Publicado: (2016)

Cardiac Manifestations in a Case of Severe Hyperkalemia
por: Saad, Syed M, et al.
Publicado: (2021)

VENTRICULAR ARRHYTHMIA AND SINUS PAUSE IN THE SETTING OF COVID-19
por: Ahmed, Jameel, et al.
Publicado: (2022)

Anxiety and depressive symptoms in patients with psoriasis
por: Sallemi, R., et al.
Publicado: (2021)

The impact of renal protection clinics on prescription of and adherence to cardioprotective drug therapy in chronic kidney disease patients
por: Lepeytre, Fanny, et al.
Publicado: (2017)

Exposure to silica and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group
por: Muntyanu, Anastasiya, et al.
Publicado: (2022)

NEIGHBORHOOD CHARACTERISTICS AND TRAJECTORIES OF DEPRESSIVE SYMPTOMS AND ANXIETY
por: Qin, Weidi
Publicado: (2022)

Psoriasis and Its Relationship With Somatosensory Amplification, Health Anxiety, and Depression
por: Gürel, Gülhan, et al.
Publicado: (2023)

The Effects of Methotrexate and Biologics on the Symptoms of Depression and Anxiety in Patients with Psoriasis
por: Uğurer, Ece, et al.
Publicado: (2023)

Trajectories of depression and anxiety symptom change during psychological therapy
por: Saunders, Rob, et al.
Publicado: (2019)

Distribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis
por: Molina-Leyva, Alejandro, et al.
Publicado: (2015)

Cost of Refractory Crohn’s Disease Before and After Ustekinumab Utilization
por: Rahme, Elham, et al.
Publicado: (2019)

A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on Tildrakizumab
por: Ghazawi, Feras M., et al.
Publicado: (2021)

Alexithymia, anxiety and depression in patients with psoriasis: a case–control study
por: Korkoliakou, Panagiota, et al.
Publicado: (2014)

A Cross-sectional Study of Prevalence and Implications of Depression and Anxiety in Psoriasis
por: Lakshmy, Sreelatha, et al.
Publicado: (2015)

Psychotherapies for Anxiety and Depression: benefits and costs
por: Sanavio, Enzo
Publicado: (2017)

Identifying Neurocognitive Decline at 36 Months among HIV-Positive Participants in the CHARTER Cohort Using Group-Based Trajectory Analysis
por: Brouillette, Marie-Josée, et al.
Publicado: (2016)

Two-way messaging therapy for depression and anxiety: longitudinal response trajectories
por: Hull, Thomas D., et al.
Publicado: (2020)

Trajectories of Depressive Symptoms and Anxiety during Pregnancy and Associations with Pregnancy Stress
por: Lee, Hyejung, et al.
Publicado: (2021)

Stable Anxiety and Depression Trajectories in Late Adolescence for Oral Contraceptive Users
por: Doornweerd, Anne Marieke, et al.
Publicado: (2022)

Association of Psoriasis With Anxiety and Depression: A Case–Control Study in Chinese Patients
por: Jing, Danrong, et al.
Publicado: (2021)

Serum 5-Hydroxytryptamine is Related to Psoriasis Severity in Patients with Comorbid Anxiety or Depression
por: SHEN, Minxue, et al.
Publicado: (2021)

Risk factors and communities disproportionately affected by cervical cancer in the Russian Federation: A national population-based study
por: Muntyanu, Anastasiya, et al.
Publicado: (2022)

Burden and geographic distribution of oral cavity and oropharyngeal cancers in the Russian Federation
por: Muntyanu, Anastasiya, et al.
Publicado: (2023)

Depression and Anxiety Trajectories among Women Who Undergo an Elective Cesarean Section
por: Kuo, Shu-Yu, et al.
Publicado: (2014)

Anxiety, Depression and Quality of Life in Older Adults: Trajectories of Influence across Age
por: Ribeiro, Oscar, et al.
Publicado: (2020)

Trajectories of sickness absence among young people with prior depression/anxiety symptoms
por: Alaie, I, et al.
Publicado: (2022)

The Costs of Psoriasis Medications
por: Mustonen, Anssi, et al.
Publicado: (2013)

Depression and anxiety among patients with psoriasis: A correlation with quality of life and associated factors
por: Bakar, Raishan S., et al.
Publicado: (2021)

Depressive, anxiety, stress, and insomnia symptoms in patients with psoriasis: a cross-sectional study
por: Soliman, Moetaza M.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_04ns5icav5pk2ddl5mb9i4cd4m